Stay updated on Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A new revision entry v3.6.3 was added to the record history, replacing the previous v3.6.2.
    Difference
    0.1%
    Check dated 2026-07-04T13:16:36.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.2) was added to the record history, replacing the previous revision (v3.6.0) to reflect an update to the page's version metadata.
    Difference
    0.1%
    Check dated 2026-06-27T05:39:29.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Recruitment status is updated to 'No longer looking for participants' in the study history. The record revision is updated to v3.6.0, replacing the prior v3.5.5.
    Difference
    0.2%
    Check dated 2026-06-13T00:29:20.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    A new page revision (v3.5.5) was added and the previous revision (v3.5.4) was removed. This indicates an update to the history page itself rather than changes to the trial data.
    Difference
    0.1%
    Check dated 2026-06-05T19:52:07.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4 on the record history page, signaling a new version of the study record has been posted.
    Difference
    0.1%
    Check dated 2026-05-15T09:18:54.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page’s interface revision was updated from v3.5.2 to v3.5.3, reflecting a maintenance/version change to the ClinicalTrials.gov site UI.
    Difference
    0.1%
    Check dated 2026-04-24T05:55:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.